BlossomHill Therapeutics, Inc.

📍 San Diego, United States🗓 Founded 2020👥 40 employees💰 Last funded Dec 2023
Biotechnology Research🌐 bhtherapeutics.com
Website LinkedIn
BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders. The company is founded by renowned drug design and development scientist, J. Jean Cui, Ph.D., and biotech business veteran, Y. Peter Li, Ph.D., M.B.A. BlossomHill Therapeutics, Inc. is headquartered in San Diego, California.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in BlossomHill Therapeutics, Inc.?
BlossomHill Therapeutics, Inc. has 1 investors on record on gritt.io, 1 mid-stage.
When did BlossomHill Therapeutics, Inc. last raise funding?
The most recent investment in BlossomHill Therapeutics, Inc. recorded on gritt.io was in December 2023.
When was BlossomHill Therapeutics, Inc. founded?
BlossomHill Therapeutics, Inc. was founded in 2020.
What industry is BlossomHill Therapeutics, Inc. in?
BlossomHill Therapeutics, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is BlossomHill Therapeutics, Inc. based?
BlossomHill Therapeutics, Inc. is headquartered in San Diego, United States.